ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,014, issued on July 7, was assigned to Chatterjee Subroto (Columbia, Md.).

"Inhibitors of glycosphingolipid synthesis and methods of use" was invented by Subroto B. Chatterjee (Columbia, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions in the prevention and treatment of skin diseases or associated disorders, inflammation or inflammatory diseases or disorders, include at least one inhibitor of glycosphingolipid synthesis."

The patent was filed on June 5, 2019, under Application No. 16/972,575.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&...